News | Contrast Media Injectors | December 13, 2021

ulrich medical and Qaelum NV finalize a strategic partnership for an advanced Contrast Management solution to track the usage of contrast agents and help harmonize protocols across CT injectors, departments and institutions

Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks.

December 13, 2021 — Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks. Contrast dose as well as Radiation exposure is an issue for every player in a patient’s treatment, from the patient, to the referring physician, to the radiology department, and to regulatory bodies. The novel Contrast Management solution and Qaelum’s proven Dose Management System will enable organizations to manage, analyse and balance their contrast agents and the patient dose.

With this strategic alliance, ulrich medical will offer a flexible solution that allows for central recording and statistical data processing of the utilization of the connected contrast injectors at enterprise level. Contrast usage can be analyzed at different levels, protocols can be harmonized and regulatory reporting needs can be simplified. The vendor-neutral solution needs only a limited time investment of the local IT department and can run both in an on-premise or cloud-based version.

“Qaelum is a leader in Advanced Dose and Contrast Management software solutions,” said Sven Erdmann, Vice President Technology and Regulation of ulrich medical. “Our strategic alliance will allow medical imaging departments to take control over the usage of their contrast media injectors and provide them the tools to harmonize and optimize their injection protocols. By combining the strengths of the quality management tools of Qaelum, with the state-of-the-art solutions of ulrich medical, including our FDA approved DICOM RIS/PACS connection, we can now offer healthcare enterprises a complete solution that will help institutions drive more value from their existing investments, now and into the future.”

“We are delighted to enter into this strategic partnership with ulrich medical,” said Jurgen Jacobs, CEO and co-founder of Qaelum. “This partnership fits perfectly in our long term strategy to improve patient safety, quality and efficiency in medical imaging departments.

For more information: www.qaelum.com

 


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | ARRS

May 7, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and ...

Time May 07, 2024
arrow
Subscribe Now